Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
ACDM24 will be the largest clinical data management conference in Europe in 2024. ACDM24 will take place in Copenhagen from the 3rd -5th March 2024. A record number of exhibiting companies, thirty five in total, joined us for the 2 days of main sessions which featured more than 50 speakers and five breakout streams in 2023. Attendees came from more than 25 countries to take part in the most successful ACDM conference to date. The attendee split was almost exactly one third Pharma/Biotech, one third CROs, and one third technology. This split of attendees makes the ACDM conferences the perfect place to learn, share, develop and network, whether you are new to the sector or one of the many senior industry people who attend.
ACDM24 promises to be even bigger and better than ACDM23.
Join IQVIA at booth #25
The Association for Clinical Data Management is a membership association that has been at the forefront of changes in the sector for over 36 years. With over 100 corporate members and close to 2000 individual members, the ACDM Conference provides an opportunity for both members and non-members to come together to discuss the present and future of clinical data management. Find out more about the ACDM here.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Ensure you have access to insights early with connected devices and clean, analysis-ready data
Decrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.
Getting the right outcomes from your clinical trials is all about the data and insights they provide. Biostatistics in clinical trials isn’t just a necessity, it can be a real competitive advantage.